Guardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, President

Dow Jones

2024/10/01

By Michael Susin

Guardion Health Sciences on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans.

The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21.

The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall.

The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations.

Write to Michael Susin at michael.susin@wsj.com

(END) Dow Jones Newswires

October 01, 2024 09:24 ET (13:24 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2472373544"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2472373544\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2472373544?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-01 21:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2472373544","market":"fut","top_or_hot":-1,"title":"Guardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, President","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Michael Susin \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/GHSI\">Guardion Health Sciences</a> on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans. \n</p>\n<p>\n  The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21. \n</p>\n<p>\n  The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall. \n</p>\n<p>\n  The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Michael Susin at michael.susin@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 01, 2024 09:24 ET (13:24 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, President</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuardion Health Sciences To Delist as It Goes Into Liquidation; Appoints Interim CEO, President\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-10-01 21:24</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Michael Susin \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/GHSI\">Guardion Health Sciences</a> on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans. \n</p>\n<p>\n  The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21. \n</p>\n<p>\n  The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall. \n</p>\n<p>\n  The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Michael Susin at michael.susin@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 01, 2024 09:24 ET (13:24 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4183","symbol_name":"个人用品","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2472373544","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2472373544","pubTimestamp":1727789040,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Guardion Health Sciences on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans.The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21.The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall.The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4183":"个人用品"},"translate_title":"Guardion Health Sciences因进入清算而退市；任命临时首席执行官、总裁","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GHSI":1},"content_text":"By Michael Susin \n\n\n \n\n\nGuardion Health Sciences on Tuesday requested the Nasdaq Stock Market to delist its stock as part of its liquidation and dissolution plans. \n\n\n  The clinical nutrition company said it expects to suspend trading of its stock prior to the opening of trading on Oct. 14, and for the official delisting to be effective Oct. 21. \n\n\n  The company also announced that it has appointed Mark Goldstone as interim president and interim chief executive, effective Oct. 18, replacing Jan Hall. \n\n\n  The liquidation plan was authorized by its shareholders on May 31. The dissolution follows the completion of the sale of the Viactiv brand and business, which left the company with minimal operations. \n\n\n \n\n\n  Write to Michael Susin at michael.susin@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 01, 2024 09:24 ET (13:24 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}